Determination of the 50% human infectious dose for Norwalk virus. - Wikidata - awgldk - TriplyDB

Determination of the 50% human infectious dose for Norwalk virus.

Determination of the 50% human infectious dose for Norwalk virus.

http://www.wikidata.org/entity/Q37635146

about

Tropical and travel-associated norovirus: current concepts Norovirus Norovirus immunology: Of mice and mechanisms Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting Norovirus Regulation by Host and Microbe.Presence of human noroviruses on bathroom surfaces: a review of the literature.Vaccine against norovirus.Critical Review on the Public Health Impact of Norovirus Contamination in Shellfish and the Environment: A UK Perspective.Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus Norovirus in healthcare settings.Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors.Identification of human single-chain antibodies with broad reactivity for noroviruses.Comprehensive review of human sapoviruses.Advances in laboratory methods for detection and typing of norovirus Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity Characterization of cross-reactive norovirus-specific monoclonal antibodies.Norovirus Dose-Response: Are Currently Available Data Informative Enough to Determine How Susceptible Humans Are to Infection from a Single Virus?Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay.Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population.Tulane Virus as a Potential Surrogate To Mimic Norovirus Behavior in Oysters Pathogenic Enteric Viruses and Microbial Indicators during Secondary Treatment of Municipal Wastewater.Vomiting as a Symptom and Transmission Risk in Norovirus Illness: Evidence from Human Challenge Studies.A Gnotobiotic Pig Model for Determining Human Norovirus Inactivation by High-Pressure Processing Norovirus Gastroenteritis in a Birth Cohort in Southern India Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus.Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies.Multicenter Evaluation of the Xpert Norovirus Assay for Detection of Norovirus Genogroups I and II in Fecal Specimens.Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation Mucosal and Cellular Immune Responses to Norwalk Virus.Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States.A Review of State Licensing Regulations to Determine Alignment with Best Practices to Prevent Human Norovirus Infections in Child-Care Centers Control of norovirus outbreak on a pediatric oncology unit Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.Digital PCR for Quantifying Norovirus in Oysters Implicated in Outbreaks, France.Inactivation of norovirus and surrogates by natural phytochemicals and bioactive substances.Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection

P2860

Q26799737-24700F6D-720C-4D3D-9F72-6EB74D784F69 Q26864280-B2B30C54-7D06-4EC7-B836-848E45C32364 Q28083087-0A1A4D97-8F2E-4EB4-B8E2-D5F0DB955CEB Q28386433-C4F6B1BC-3CD8-4D64-9FB8-499E66266876 Q30240631-426ECBD2-22D1-4022-B2A9-23DCF0C15274 Q30251950-855EFFA3-59DB-4CE1-8B0C-0674D4302E38 Q33578075-50EE87E7-E196-4B7C-B1EC-02C7391AD1E0 Q33676685-D8429149-1CCB-4D66-B518-50F41881BB19 Q33703664-6B50ABAA-14FF-49D2-AE1E-A6585DB532B1 Q33743992-95643758-C572-4B65-B8F3-D5D4ADA80407 Q33798787-3A0781D4-BB41-4E39-B210-8A1F0F1BAFB1 Q34134280-67D8517A-AEC3-4E11-BF00-AB45F0DD5F6B Q34262075-5C41125E-73A1-4FE1-B7E8-82BDAA49C544 Q34313167-D5305FC4-FF21-4B7A-A5F2-E1F608CC2B95 Q34826743-A429BCB6-C27F-4694-A4AB-CC2B635DC666 Q34983000-4173843E-7CA0-46A9-B7F3-03C6327D6A0B Q35021149-1AE63343-D9B8-428E-B662-7750EAB433C0 Q35021153-409D6C22-EFE0-474E-A2BE-41DF8D10EF5A Q35529755-0CBF1D29-72F9-4A79-BF5A-17D91E3B67E6 Q35610684-64EA3907-8155-4384-B635-47D52AB05219 Q35615462-CF9E3571-CDC5-48B2-8568-82EBDE523CC7 Q35661724-4A20ECE2-130A-4ACE-BF33-4F71506AF64F Q35829423-08426453-A54F-48BB-B413-BA9FA1632CCE Q35973176-7B06634A-185A-4055-979E-EF28563C5AB1 Q35999619-405A8647-AF99-4DDD-A023-358A98E2322F Q36033161-350AB2D9-2A9D-432C-91AC-9747449E855B Q36048013-B01BD935-33C8-41E4-AE98-752C9A6D9280 Q36063949-FFEE4E65-C06C-4056-9AF2-B50A49F186D3 Q36236047-69FA62DE-D714-43FD-A497-5B433156B232 Q36297638-1098D0AE-4C19-4977-BD09-3A5E7B71336C Q36434360-9C8E4559-E5DC-4420-8EB2-4178498E5D72 Q36642590-298EE6EF-3622-4FE8-9867-3D6A2F5D6B97 Q36756413-C3BAA708-1632-47D0-8AE9-145843152FDA Q36867575-1EFC5D17-EBD9-4FBE-BE0D-8CD73B9C9179 Q36906749-1F70D263-39F9-400C-8E64-0A10D889501B Q37182843-D11CA2E7-FAC3-428D-9D0E-402BB51BCB0E Q37252978-38ADB701-BA5F-4437-AD82-DE9634D90962 Q37535881-55E2C8FD-FB60-4926-8389-3F3714EC431C Q38269752-E36D91D4-2325-49FD-9DAE-6C1E0C33C5AF Q38280209-F985DDF4-C056-42AC-9933-62F4F4979CD2

P2860

Determination of the 50% human infectious dose for Norwalk virus.

http://www.wikidata.org/entity/Q37635146

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Determination of the 50% human infectious dose for Norwalk virus.

@en

Determination of the 50% human infectious dose for Norwalk virus.

@nl

type

label

Determination of the 50% human infectious dose for Norwalk virus.

@en

Determination of the 50% human infectious dose for Norwalk virus.

@nl

prefLabel

Determination of the 50% human infectious dose for Norwalk virus.

@en

Determination of the 50% human infectious dose for Norwalk virus.

@nl

P1433

Q37635146-F47EDC44-7E20-499D-8D7C-ED8D68ACC5B8

P1476

Q37635146-94D7F005-0C56-43B6-84A9-88C39F897CCA

P2093

Q37635146-06FD9F7E-AEA5-4C70-93E3-1A6FB9981952

Q37635146-087EC787-C953-4D39-8C86-AFE0BEA5C572

Q37635146-172048E6-5710-4B4F-B0A7-21DED6EB751E

Q37635146-3F145FAF-D23C-4526-8FAE-D23ED85ACA2A

Q37635146-683F55DF-3C7F-4161-BFBA-9A9BB0463F52

Q37635146-9F2850A1-8166-44C0-8C26-E232E48076DD

Q37635146-AC396E8E-672D-4439-B61F-FAE936F8D162

P2860

Q37635146-00C65551-5213-4224-97BD-2706ECA8F9A9

Q37635146-1151C5A7-7E2F-4DD3-8E22-409B22D37E9B

Q37635146-13F77380-0E33-4B2E-9194-77789AF466B1

Q37635146-1CA26A57-3219-41D9-8959-1860A559EBB9

Q37635146-1F459DBE-FF2D-413D-8661-31EB847D6BE4

Q37635146-216B18BC-9635-4E1D-B64E-177AA40593B5

Q37635146-29C6918C-96CF-4FFE-9BF0-C193DC03F334

Q37635146-2CD14F65-106D-4CBE-9E69-6D8F05E252FC

Q37635146-2D081181-3915-4B37-8FB0-C456BE5033CA

Q37635146-2FD14084-CCFE-4590-B763-714F48DEF38D

P304

Q37635146-5B5FAA52-F652-48CA-B20F-0B9843DA8A1D

P31

Q37635146-6878E40F-E62E-422E-96D3-C610E878398C

P356

Q37635146-C3818498-5080-4F9A-911E-B54B2896979B

P407

Q37635146-C5BE6590-4E19-4D2C-8CED-AC28BF2A35D2

P433

Q37635146-4F95ADB7-E5EB-4B3A-93BE-3F145D852062

P478

Q37635146-90F3BCEC-EEF7-422A-B759-05595EABCF1B

P50

Q37635146-AD2800C6-EB09-465B-9CA9-A931963A8343

Q37635146-C4DA7522-927C-4C0A-8E50-37DC891CCC56

Q37635146-FD7552FB-BAF6-46BB-8D1B-81464426631B

P577

Q37635146-AAB6C1D1-A7CA-4FA0-85EF-091B6DA1F586

P5875

Q37635146-161D9F70-2987-4E7F-A4AD-18954E159F8C

P698

Q37635146-C9D8DEA4-3203-4235-8D98-85E01438B584

P921

Q37635146-FCD04D88-CD00-4A73-986A-69C69A443A1C

P932

Q37635146-36820382-847D-4A2B-A969-4E5708649394

P356

P1433

The Journal of Infectious Diseases

P1476

Determination of the 50% human infectious dose for Norwalk virus.

@en

P2093

Antone R Opekun

http://www.w3.org/2001/XMLSchema#string

Frederick H Neill

http://www.w3.org/2001/XMLSchema#string

Heather Hill

http://www.w3.org/2001/XMLSchema#string

Jennifer Ferreira

http://www.w3.org/2001/XMLSchema#string

Mark A Gilger

http://www.w3.org/2001/XMLSchema#string

Sasirekha Ramani

http://www.w3.org/2001/XMLSchema#string

Sue E Crawford

http://www.w3.org/2001/XMLSchema#string

P2860

Norwalk virus shedding after experimental human infection

Cellular and humoral immunity following Snow Mountain virus challenge

Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer

Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant

Human susceptibility and resistance to Norwalk virus infection

Norovirus disease in the United States.

Tissue distribution of histo-blood group antigens.

Serological correlate of protection against norovirus-induced gastroenteritis

Norwalk virus infection and disease is associated with ABO histo-blood group type.

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay

P304

1016-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIT620

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

209

http://www.w3.org/2001/XMLSchema#string

P50

David Y. Graham

P577

2013-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258766721

http://www.w3.org/2001/XMLSchema#string

P698

24253285

http://www.w3.org/2001/XMLSchema#string

P921

P932

3952671

http://www.w3.org/2001/XMLSchema#string